Atara Biotherapeutics Reports Q3 2024 Financial Progress

TipRanksNov 14 11:59

Atara Biotherapeutics to Participate at the Stifel 2024 Healthcare Conference

BusinesswireNov 14 05:01

CCORF Maintains Atara Biotherapeutics(ATRA.US) With Buy Rating, Raises Target Price to $21

Futu NewsNov 13 21:31 · Ratings

Canaccord Genuity Maintains Buy on Atara Biotherapeutics, Raises Price Target to $21

BenzingaNov 13 21:26 · Ratings

Atara Biotherapeutics GAAP EPS of -$2.93 Beats by $17.16, Revenue of $40.19M Beats by $5.02M

Seeking AlphaNov 13 05:55

Atara Biotherapeutics Advances With Strategic Partnerships

TipRanksNov 13 05:45